Search by Drug Name or NDC
NDC 36800-0246-60 topcare headache relief 250; 250; 65 mg/1; mg/1; mg/1 Details
topcare headache relief 250; 250; 65 mg/1; mg/1; mg/1
topcare headache relief is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Topco Associates LLC. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 36800-0246 |
|---|---|
| Product ID | 36800-246_ad12cf2b-5de4-4cad-ad26-a4f400c86c8f |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | topcare headache relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | acetaminophen, aspirin, caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | Topco Associates LLC |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part343 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 36800-0246-60 (36800024660)
| NDC Package Code | 36800-246-60 |
|---|---|
| Billing NDC | 36800024660 |
| Package | 1 BOTTLE in 1 CARTON (36800-246-60) / 20 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2022-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |